Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The consumption of antibiotics has increased significantly over the past 15 years, according to a recent study. The increase occurred despite the international push to reduce the use of these important drugs.

Researchers found that while many low- and middle-income countries still lack appropriate access to antibiotics, the global increase was driven largely by some developing countries which face more drug-resistant infections and a lack of tools to test infections and track how these medications are used.

To tackle antimicrobial resistance (AMR), we need to look at all the factors behind how and when antibiotics are used. One obstacle I often see as a medical microbiologist working in developing countries, is a lack of access to clean water, which makes preventing and controlling infections nearly impossible. It is a major driver of inappropriate antibiotic use and, ultimately, the growth in antibiotic-resistant bugs – so-called “superbugs”.

Read the full article on The Conversation website, written by Abhilasha Karkey (Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine). 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.